AXS-05

dextromethorphan-quinidine · Axsome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for AXS-05, covering 2021-03-24 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation [Phase 3]